Bilirubin
Reactions involving Bilirubin
Every recorded step where this molecule takes part
-
consumed Bilirubin UDP-glucuronosyltransferase (UGT1A1) Heme Degradation (Bilirubin Pathway) ST-0188 rate-limiting
Bilirubin + 2 UDP-glucuronic acid → bilirubin mono- and predominantly diglucuronide + 2 UDP
Showing all 1 reactions.
Recent literature
Europe PMC · fetched just now · sorted by publication date
-
1
Efficacy and Safety of Endoscopic Ultrasound-Guided Biliary Drainage in the Management of Malignant Hilar Biliary Obstruction: A Multicenter Retrospective Cohort Study.
Iwashita T, Hayashi K, Yoshida M, Yamada R, Matsuda K, Morita S, Inoue T, Shioji K, Iwata K, Maruta A, Hayash… · 2026-08-24
open access unreviewed -
2
A bioactivity-enhanced thermosensitive amnion-derived hydrogel with sustained IGF-1 release: A multitargeted and efficient strategy for corneal injury repair.
Xie M, Li A, Sun X, Liu J, Wei Y, Yang H, Chen S, Zhong X, Quan D, Guan X, Tian L, Jie Y. · 2026-09-16
open access unreviewed -
3
A transferrin receptor-targeted liposome for iron metabolism regulation-augmented photodynamic therapy in glioblastoma.
Wen R, He G, Wan Y, Guo X, Xiong S, Wu Y, Wei Y, Li D, Lin J, Huang P. · 2026-09-16
open access unreviewed -
4
Functionalized biomaterial platforms for interventional embolization therapy of hepatocellular carcinoma.
Zheng N, Tang Z, Yang G, Deng L, Zhao Q, Zhao Y, Zhang J, Wang X, Chai Y, Chen Y, Wu Y, Fu Y, Liu S, Li J, Lu… · 2026-09-08
open access unreviewed -
5
CyberKnife SBRT plus lenvatinib and tislelizumab versus doublet systemic therapy for hepatocellular carcinoma with macrovascular invasion: A real-world IPTW-adjusted study.
Zhang S, Shen X, Wang W, Zhang M, Wang S, Hao H, Zhao Y. · 2026-09-12
open access unreviewed -
6
On-demand and Shorter Duration Versus Standard-duration Antibiotic Prophylaxis in Cirrhotic Patients With Variceal Bleeding: A Systematic Review and Meta-analysis.
Bot KKIM, de Wit K, Remmelzwaal S, Maan R, Drenth JPH, Lantinga MA. · 2026-08-27
unreviewed -
7
Babaodan ameliorates metabolic dysfunction-associated steatotic liver disease with co-modulation of FXR, NF-κB, and SLC22A7 in bile acid metabolism.
Qiu S, Qiang S, Wang Z, Yang L, Guo S, Zeng J, Cai Y, Lai Z, Xie D, Che L, Zhang A. · 2026-07-19
unreviewed -
8
Routine health examination indicators for fatty liver disease risk stratification in adults with thyroid dysfunction: a cross-sectional study of 46,311 individuals.
Wang C, Rao H, Zhang X, Zhang G, Xia G, Zhang L. · 2026-10-03
open access unreviewed -
9
Clinical considerations on the use of evinacumab for the treatment of homozygous familial hypercholesterolemia.
Bajaj A, McGuire M, Shugg S, Godin R, Underberg JA. · 2026-08-11
open access unreviewed -
10
Scoparone protects against acetaminophen-induced acute liver injury: Insights from In vivo experiments and RNA sequencing.
Lv J, Liu L, Xia M, Yao Y, Jin G. · 2026-09-22
open access unreviewed
External claims. These come from an index outside this database and are not checked against it. Treat them as leads.